nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—skin cancer—psoriasis	0.51	1	CtDrD
Fluorouracil—MTHFR—Methotrexate—psoriasis	0.0296	0.0889	CbGbCtD
Fluorouracil—TYMS—Methotrexate—psoriasis	0.0252	0.0757	CbGbCtD
Fluorouracil—CYP2A6—Methoxsalen—psoriasis	0.0252	0.0757	CbGbCtD
Fluorouracil—ABCC3—Cyclosporine—psoriasis	0.0247	0.0742	CbGbCtD
Fluorouracil—ALB—Acitretin—psoriasis	0.0197	0.0592	CbGbCtD
Fluorouracil—CYP2C8—Tazarotene—psoriasis	0.0192	0.0579	CbGbCtD
Fluorouracil—CYP1A2—Clobetasol propionate—psoriasis	0.0183	0.055	CbGbCtD
Fluorouracil—ABCG2—Mycophenolate mofetil—psoriasis	0.0134	0.0402	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—psoriasis	0.0131	0.0393	CbGbCtD
Fluorouracil—CYP2A6—Prednisolone—psoriasis	0.0122	0.0368	CbGbCtD
Fluorouracil—ABCG2—Hydrocortisone—psoriasis	0.0107	0.0323	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—psoriasis	0.0102	0.0307	CbGbCtD
Fluorouracil—ABCG2—Cyclosporine—psoriasis	0.0101	0.0305	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—psoriasis	0.00997	0.03	CbGbCtD
Fluorouracil—CYP1A2—Methoxsalen—psoriasis	0.0096	0.0289	CbGbCtD
Fluorouracil—ALB—Mycophenolate mofetil—psoriasis	0.00922	0.0277	CbGbCtD
Fluorouracil—CYP2C8—Cholecalciferol—psoriasis	0.00822	0.0247	CbGbCtD
Fluorouracil—ALB—Prednisone—psoriasis	0.00737	0.0222	CbGbCtD
Fluorouracil—CYP2A6—Dexamethasone—psoriasis	0.00721	0.0217	CbGbCtD
Fluorouracil—CYP2C8—Mycophenolate mofetil—psoriasis	0.00712	0.0214	CbGbCtD
Fluorouracil—ABCG2—Dexamethasone—psoriasis	0.00667	0.0201	CbGbCtD
Fluorouracil—CYP2C9—Cholecalciferol—psoriasis	0.00573	0.0172	CbGbCtD
Fluorouracil—CYP2C8—Hydrocortisone—psoriasis	0.00572	0.0172	CbGbCtD
Fluorouracil—CYP2C8—Cyclosporine—psoriasis	0.0054	0.0162	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—psoriasis	0.00536	0.0161	CbGbCtD
Fluorouracil—CYP2C9—Cyclosporine—psoriasis	0.00377	0.0113	CbGbCtD
Fluorouracil—ALB—Methotrexate—psoriasis	0.0037	0.0111	CbGbCtD
Fluorouracil—CYP2C8—Dexamethasone—psoriasis	0.00355	0.0107	CbGbCtD
Fluorouracil—CYP2C9—Dexamethasone—psoriasis	0.00248	0.00746	CbGbCtD
Fluorouracil—TYMS—Vitamin A—Acitretin—psoriasis	0.000299	0.113	CbGdCrCtD
Fluorouracil—TYMS—Alitretinoin—Acitretin—psoriasis	0.000209	0.0791	CbGdCrCtD
Fluorouracil—TYMS—Tretinoin—Acitretin—psoriasis	0.000209	0.0791	CbGdCrCtD
Fluorouracil—TYMS—Isotretinoin—Acitretin—psoriasis	0.000209	0.0791	CbGdCrCtD
Fluorouracil—MTHFR—Selenium Micronutrient Network—ICAM1—psoriasis	0.000105	0.00412	CbGpPWpGaD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000104	0.0041	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000103	0.00403	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CYP2S1—psoriasis	0.000102	0.004	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CYP2S1—psoriasis	0.000102	0.004	CbGpPWpGaD
Fluorouracil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000101	0.00395	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—IFNG—psoriasis	0.0001	0.00395	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—TGFA—psoriasis	0.0001	0.00393	CbGpPWpGaD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—TP53—psoriasis	9.98e-05	0.00392	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	9.69e-05	0.00381	CbGpPWpGaD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	9.48e-05	0.00372	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—TGFA—psoriasis	9.4e-05	0.00369	CbGpPWpGaD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—TP53—psoriasis	8.69e-05	0.00341	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—NDUFA5—psoriasis	8.53e-05	0.00335	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—NFKB1—psoriasis	8.36e-05	0.00328	CbGpPWpGaD
Fluorouracil—TYMS—G1/S Transition—PCNA—psoriasis	8.09e-05	0.00318	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—TNF—psoriasis	7.99e-05	0.00314	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—IFNG—psoriasis	7.98e-05	0.00313	CbGpPWpGaD
Fluorouracil—TYMS—Fluoropyrimidine Activity—TP53—psoriasis	7.74e-05	0.00304	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CARM1—psoriasis	7.72e-05	0.00303	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	7.71e-05	0.00303	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—CYP2S1—psoriasis	7.69e-05	0.00302	CbGpPWpGaD
Fluorouracil—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	7.58e-05	0.00298	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	7.47e-05	0.00294	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CYP2S1—psoriasis	7.26e-05	0.00285	CbGpPWpGaD
Fluorouracil—ALB—Lipoprotein metabolism—APOE—psoriasis	7.21e-05	0.00283	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CARM1—psoriasis	7.17e-05	0.00282	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CARM1—psoriasis	7.17e-05	0.00282	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—CP—psoriasis	6.88e-05	0.0027	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—PCNA—psoriasis	6.82e-05	0.00268	CbGpPWpGaD
Fluorouracil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.67e-05	0.00262	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—NFKB1—psoriasis	6.64e-05	0.00261	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—CARM1—psoriasis	6.56e-05	0.00258	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—TNF—psoriasis	6.5e-05	0.00255	CbGpPWpGaD
Fluorouracil—MTHFR—Vitamin B12 Metabolism—IL6—psoriasis	6.45e-05	0.00253	CbGpPWpGaD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—TP53—psoriasis	6.41e-05	0.00252	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFA—psoriasis	6.27e-05	0.00246	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—CYP2S1—psoriasis	6.26e-05	0.00246	CbGpPWpGaD
Fluorouracil—TYMS—Triamcinolone—Clobetasol propionate—psoriasis	6.25e-05	0.0236	CbGdCrCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	6.22e-05	0.00244	CbGpPWpGaD
Fluorouracil—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	6.17e-05	0.00242	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—PTTG1—psoriasis	6.14e-05	0.00241	CbGpPWpGaD
Fluorouracil—TYMS—Fluticasone Propionate—Clobetasol propionate—psoriasis	6.09e-05	0.023	CbGdCrCtD
Fluorouracil—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	6.08e-05	0.00239	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	6.02e-05	0.00237	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	5.96e-05	0.00234	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINB8—psoriasis	5.88e-05	0.00231	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.8e-05	0.00228	CbGpPWpGaD
Fluorouracil—TYMS—Diflorasone—Clobetasol propionate—psoriasis	5.76e-05	0.0218	CbGdCrCtD
Fluorouracil—MTHFR—Folate Metabolism—TP53—psoriasis	5.73e-05	0.00225	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	5.71e-05	0.00224	CbGpPWpGaD
Fluorouracil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.7e-05	0.00224	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—NDUFA5—psoriasis	5.63e-05	0.00221	CbGpPWpGaD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	5.62e-05	0.00221	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—PTTG1—psoriasis	5.49e-05	0.00215	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—CYP2S1—psoriasis	5.35e-05	0.0021	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	5.27e-05	0.00207	CbGpPWpGaD
Fluorouracil—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	5.26e-05	0.00207	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—IL6—psoriasis	5.25e-05	0.00206	CbGpPWpGaD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	5.18e-05	0.00204	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	5.17e-05	0.00203	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—TNF—psoriasis	5.17e-05	0.00203	CbGpPWpGaD
Fluorouracil—TYMS—Clobetasol propionate—Beclomethasone—psoriasis	5.12e-05	0.0194	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Fluocinonide—psoriasis	5.12e-05	0.0194	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Fluocinonide—psoriasis	5.05e-05	0.0191	CbGdCrCtD
Fluorouracil—TYMS—Budesonide—Clobetasol propionate—psoriasis	5.05e-05	0.0191	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Fluocinonide—psoriasis	5e-05	0.0189	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Beclomethasone—psoriasis	5e-05	0.0189	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	4.98e-05	0.0188	CbGdCrCtD
Fluorouracil—PPAT—Metabolism—CARM1—psoriasis	4.97e-05	0.00195	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CARM1—psoriasis	4.97e-05	0.00195	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—CAT—psoriasis	4.94e-05	0.00194	CbGpPWpGaD
Fluorouracil—TYMS—Flunisolide—Fluocinolone Acetonide—psoriasis	4.91e-05	0.0186	CbGdCrCtD
Fluorouracil—ABCC5—Metabolism—NDUFA5—psoriasis	4.9e-05	0.00192	CbGpPWpGaD
Fluorouracil—TYMS—Fluticasone Propionate—Fluocinonide—psoriasis	4.88e-05	0.0184	CbGdCrCtD
Fluorouracil—TYMS—Fluticasone Propionate—Beclomethasone—psoriasis	4.88e-05	0.0184	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Fluocinolone Acetonide—psoriasis	4.86e-05	0.0184	CbGdCrCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—CRP—psoriasis	4.82e-05	0.00189	CbGpPWpGaD
Fluorouracil—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	4.79e-05	0.00188	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CYP2S1—psoriasis	4.79e-05	0.00188	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CAT—psoriasis	4.75e-05	0.00186	CbGpPWpGaD
Fluorouracil—TYMS—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	4.74e-05	0.0179	CbGdCrCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—APOE—psoriasis	4.72e-05	0.00185	CbGpPWpGaD
Fluorouracil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.65e-05	0.00183	CbGpPWpGaD
Fluorouracil—CYP1A2—Tryptophan metabolism—CAT—psoriasis	4.61e-05	0.00181	CbGpPWpGaD
Fluorouracil—TYMS—Diflorasone—Fluocinonide—psoriasis	4.61e-05	0.0174	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Beclomethasone—psoriasis	4.61e-05	0.0174	CbGdCrCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	4.55e-05	0.00179	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL4—psoriasis	4.54e-05	0.00178	CbGpPWpGaD
Fluorouracil—TYMS—Diflorasone—Fluocinolone Acetonide—psoriasis	4.48e-05	0.0169	CbGdCrCtD
Fluorouracil—TYMS—Circadian rythm related genes—LEP—psoriasis	4.47e-05	0.00176	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	4.43e-05	0.00174	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	4.42e-05	0.00173	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CAT—psoriasis	4.41e-05	0.00173	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CAT—psoriasis	4.41e-05	0.00173	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—NDUFA5—psoriasis	4.37e-05	0.00171	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	4.35e-05	0.00171	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.34e-05	0.0017	CbGpPWpGaD
Fluorouracil—Insomnia—Cyclosporine—psoriasis	4.27e-05	0.000331	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Methotrexate—psoriasis	4.27e-05	0.00033	CcSEcCtD
Fluorouracil—Paraesthesia—Cyclosporine—psoriasis	4.24e-05	0.000328	CcSEcCtD
Fluorouracil—Dyspnoea—Cyclosporine—psoriasis	4.21e-05	0.000326	CcSEcCtD
Fluorouracil—Somnolence—Cyclosporine—psoriasis	4.2e-05	0.000325	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	4.2e-05	0.000325	CcSEcCtD
Fluorouracil—Oedema—Hydrocortisone—psoriasis	4.2e-05	0.000325	CcSEcCtD
Fluorouracil—Anaphylactic shock—Hydrocortisone—psoriasis	4.2e-05	0.000325	CcSEcCtD
Fluorouracil—Convulsion—Triamcinolone—psoriasis	4.2e-05	0.000325	CcSEcCtD
Fluorouracil—Tachycardia—Prednisolone—psoriasis	4.19e-05	0.000325	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Methotrexate—psoriasis	4.19e-05	0.000324	CcSEcCtD
Fluorouracil—Infection—Hydrocortisone—psoriasis	4.17e-05	0.000323	CcSEcCtD
Fluorouracil—MTHFR—Selenium Micronutrient Network—IL6—psoriasis	4.17e-05	0.00164	CbGpPWpGaD
Fluorouracil—Insomnia—Mycophenolate mofetil—psoriasis	4.17e-05	0.000322	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—CYP2S1—psoriasis	4.17e-05	0.00164	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—NOS2—psoriasis	4.17e-05	0.00164	CbGpPWpGaD
Fluorouracil—Dyspepsia—Cyclosporine—psoriasis	4.16e-05	0.000322	CcSEcCtD
Fluorouracil—Nausea—Hydroxyurea—psoriasis	4.14e-05	0.00032	CcSEcCtD
Fluorouracil—Paraesthesia—Mycophenolate mofetil—psoriasis	4.14e-05	0.00032	CcSEcCtD
Fluorouracil—Pruritus—Mycophenolic acid—psoriasis	4.13e-05	0.00032	CcSEcCtD
Fluorouracil—Myalgia—Triamcinolone—psoriasis	4.12e-05	0.000319	CcSEcCtD
Fluorouracil—Nervous system disorder—Hydrocortisone—psoriasis	4.12e-05	0.000319	CcSEcCtD
Fluorouracil—Pneumonia—Methotrexate—psoriasis	4.12e-05	0.000319	CcSEcCtD
Fluorouracil—Dyspnoea—Mycophenolate mofetil—psoriasis	4.11e-05	0.000318	CcSEcCtD
Fluorouracil—Decreased appetite—Cyclosporine—psoriasis	4.11e-05	0.000318	CcSEcCtD
Fluorouracil—Tachycardia—Hydrocortisone—psoriasis	4.1e-05	0.000317	CcSEcCtD
Fluorouracil—Somnolence—Mycophenolate mofetil—psoriasis	4.1e-05	0.000317	CcSEcCtD
Fluorouracil—Infestation—Methotrexate—psoriasis	4.09e-05	0.000317	CcSEcCtD
Fluorouracil—Infestation NOS—Methotrexate—psoriasis	4.09e-05	0.000317	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Cyclosporine—psoriasis	4.08e-05	0.000316	CcSEcCtD
Fluorouracil—Discomfort—Triamcinolone—psoriasis	4.07e-05	0.000315	CcSEcCtD
Fluorouracil—Dyspepsia—Mycophenolate mofetil—psoriasis	4.06e-05	0.000314	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Beclomethasone—psoriasis	4.04e-05	0.0153	CbGdCrCtD
Fluorouracil—TYMS—Budesonide—Fluocinonide—psoriasis	4.04e-05	0.0153	CbGdCrCtD
Fluorouracil—Pain—Cyclosporine—psoriasis	4.04e-05	0.000313	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	4.01e-05	0.00158	CbGpPWpGaD
Fluorouracil—Decreased appetite—Mycophenolate mofetil—psoriasis	4.01e-05	0.00031	CcSEcCtD
Fluorouracil—Anorexia—Hydrocortisone—psoriasis	4e-05	0.00031	CcSEcCtD
Fluorouracil—Diarrhoea—Mycophenolic acid—psoriasis	3.99e-05	0.000309	CcSEcCtD
Fluorouracil—Stomatitis—Methotrexate—psoriasis	3.99e-05	0.000309	CcSEcCtD
Fluorouracil—Conjunctivitis—Methotrexate—psoriasis	3.98e-05	0.000308	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	3.98e-05	0.000308	CcSEcCtD
Fluorouracil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.98e-05	0.00156	CbGpPWpGaD
Fluorouracil—Anaphylactic shock—Triamcinolone—psoriasis	3.95e-05	0.000306	CcSEcCtD
Fluorouracil—Oedema—Triamcinolone—psoriasis	3.95e-05	0.000306	CcSEcCtD
Fluorouracil—Pain—Mycophenolate mofetil—psoriasis	3.94e-05	0.000305	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Fluocinolone Acetonide—psoriasis	3.93e-05	0.0148	CbGdCrCtD
Fluorouracil—Arrhythmia—Prednisone—psoriasis	3.93e-05	0.000304	CcSEcCtD
Fluorouracil—Infection—Triamcinolone—psoriasis	3.93e-05	0.000304	CcSEcCtD
Fluorouracil—ABCC4—Platelet degranulation—VEGFA—psoriasis	3.93e-05	0.00154	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—CAT—psoriasis	3.92e-05	0.00154	CbGpPWpGaD
Fluorouracil—Hypotension—Hydrocortisone—psoriasis	3.92e-05	0.000303	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—CRP—psoriasis	3.92e-05	0.00154	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	3.92e-05	0.00154	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—PPARG—psoriasis	3.9e-05	0.00153	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Cyclosporine—psoriasis	3.89e-05	0.000301	CcSEcCtD
Fluorouracil—Insomnia—Prednisolone—psoriasis	3.89e-05	0.000301	CcSEcCtD
Fluorouracil—Alopecia—Prednisone—psoriasis	3.88e-05	0.000301	CcSEcCtD
Fluorouracil—Dizziness—Mycophenolic acid—psoriasis	3.86e-05	0.000299	CcSEcCtD
Fluorouracil—Epistaxis—Methotrexate—psoriasis	3.86e-05	0.000299	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisolone—psoriasis	3.86e-05	0.000299	CcSEcCtD
Fluorouracil—Tachycardia—Triamcinolone—psoriasis	3.86e-05	0.000298	CcSEcCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	3.84e-05	0.00151	CbGpPWpGaD
Fluorouracil—Erythema—Prednisone—psoriasis	3.83e-05	0.000296	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.82e-05	0.000296	CcSEcCtD
Fluorouracil—Agranulocytosis—Methotrexate—psoriasis	3.82e-05	0.000296	CcSEcCtD
Fluorouracil—Convulsion—Dexamethasone—psoriasis	3.81e-05	0.000295	CcSEcCtD
Fluorouracil—Convulsion—Betamethasone—psoriasis	3.81e-05	0.000295	CcSEcCtD
Fluorouracil—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.8e-05	0.000294	CcSEcCtD
Fluorouracil—Insomnia—Hydrocortisone—psoriasis	3.8e-05	0.000294	CcSEcCtD
Fluorouracil—ABCC4—Hemostasis—ITGAL—psoriasis	3.78e-05	0.00148	CbGpPWpGaD
Fluorouracil—Paraesthesia—Hydrocortisone—psoriasis	3.77e-05	0.000292	CcSEcCtD
Fluorouracil—Urticaria—Cyclosporine—psoriasis	3.75e-05	0.00029	CcSEcCtD
Fluorouracil—Myalgia—Dexamethasone—psoriasis	3.74e-05	0.000289	CcSEcCtD
Fluorouracil—Myalgia—Betamethasone—psoriasis	3.74e-05	0.000289	CcSEcCtD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.74e-05	0.00147	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	3.74e-05	0.00147	CbGpPWpGaD
Fluorouracil—Body temperature increased—Cyclosporine—psoriasis	3.73e-05	0.000289	CcSEcCtD
Fluorouracil—Vomiting—Mycophenolic acid—psoriasis	3.71e-05	0.000287	CcSEcCtD
Fluorouracil—TYMS—Metabolism—CYP2S1—psoriasis	3.71e-05	0.00146	CbGpPWpGaD
Fluorouracil—Discomfort—Betamethasone—psoriasis	3.7e-05	0.000286	CcSEcCtD
Fluorouracil—Discomfort—Dexamethasone—psoriasis	3.7e-05	0.000286	CcSEcCtD
Fluorouracil—Dyspepsia—Hydrocortisone—psoriasis	3.7e-05	0.000286	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—psoriasis	3.69e-05	0.000286	CcSEcCtD
Fluorouracil—UMPS—Metabolism—APOE—psoriasis	3.69e-05	0.00145	CbGpPWpGaD
Fluorouracil—Rash—Mycophenolic acid—psoriasis	3.68e-05	0.000285	CcSEcCtD
Fluorouracil—Dermatitis—Mycophenolic acid—psoriasis	3.68e-05	0.000285	CcSEcCtD
Fluorouracil—Pain—Prednisolone—psoriasis	3.68e-05	0.000284	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—psoriasis	3.67e-05	0.000284	CcSEcCtD
Fluorouracil—Urticaria—Mycophenolate mofetil—psoriasis	3.66e-05	0.000283	CcSEcCtD
Fluorouracil—Headache—Mycophenolic acid—psoriasis	3.66e-05	0.000283	CcSEcCtD
Fluorouracil—Decreased appetite—Hydrocortisone—psoriasis	3.65e-05	0.000282	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—psoriasis	3.65e-05	0.000282	CcSEcCtD
Fluorouracil—Body temperature increased—Mycophenolate mofetil—psoriasis	3.64e-05	0.000282	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.62e-05	0.00028	CcSEcCtD
Fluorouracil—ABCC3—Metabolism—NDUFA5—psoriasis	3.61e-05	0.00142	CbGpPWpGaD
Fluorouracil—Vision blurred—Prednisone—psoriasis	3.61e-05	0.000279	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—ICAM1—psoriasis	3.61e-05	0.00142	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.6e-05	0.000279	CcSEcCtD
Fluorouracil—Pain—Hydrocortisone—psoriasis	3.59e-05	0.000278	CcSEcCtD
Fluorouracil—Oedema—Dexamethasone—psoriasis	3.59e-05	0.000277	CcSEcCtD
Fluorouracil—Oedema—Betamethasone—psoriasis	3.59e-05	0.000277	CcSEcCtD
Fluorouracil—Anaphylactic shock—Betamethasone—psoriasis	3.59e-05	0.000277	CcSEcCtD
Fluorouracil—Anaphylactic shock—Dexamethasone—psoriasis	3.59e-05	0.000277	CcSEcCtD
Fluorouracil—Insomnia—Triamcinolone—psoriasis	3.58e-05	0.000277	CcSEcCtD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—psoriasis	3.56e-05	0.0014	CbGpPWpGaD
Fluorouracil—Infection—Betamethasone—psoriasis	3.56e-05	0.000276	CcSEcCtD
Fluorouracil—Infection—Dexamethasone—psoriasis	3.56e-05	0.000276	CcSEcCtD
Fluorouracil—Paraesthesia—Triamcinolone—psoriasis	3.55e-05	0.000275	CcSEcCtD
Fluorouracil—TYMP—Metabolism—CARM1—psoriasis	3.54e-05	0.00139	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Prednisolone—psoriasis	3.54e-05	0.000274	CcSEcCtD
Fluorouracil—Anaemia—Prednisone—psoriasis	3.54e-05	0.000274	CcSEcCtD
Fluorouracil—Dyspnoea—Triamcinolone—psoriasis	3.52e-05	0.000273	CcSEcCtD
Fluorouracil—Nervous system disorder—Betamethasone—psoriasis	3.52e-05	0.000272	CcSEcCtD
Fluorouracil—Nervous system disorder—Dexamethasone—psoriasis	3.52e-05	0.000272	CcSEcCtD
Fluorouracil—Thrombocytopenia—Betamethasone—psoriasis	3.51e-05	0.000272	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dexamethasone—psoriasis	3.51e-05	0.000272	CcSEcCtD
Fluorouracil—Tachycardia—Dexamethasone—psoriasis	3.5e-05	0.000271	CcSEcCtD
Fluorouracil—Tachycardia—Betamethasone—psoriasis	3.5e-05	0.000271	CcSEcCtD
Fluorouracil—Hypersensitivity—Cyclosporine—psoriasis	3.48e-05	0.000269	CcSEcCtD
Fluorouracil—Dyspepsia—Triamcinolone—psoriasis	3.48e-05	0.000269	CcSEcCtD
Fluorouracil—Nausea—Mycophenolic acid—psoriasis	3.47e-05	0.000268	CcSEcCtD
Fluorouracil—Feeling abnormal—Hydrocortisone—psoriasis	3.46e-05	0.000268	CcSEcCtD
Fluorouracil—UPP2—Metabolism—APOE—psoriasis	3.43e-05	0.00135	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—APOE—psoriasis	3.43e-05	0.00135	CbGpPWpGaD
Fluorouracil—Anorexia—Betamethasone—psoriasis	3.42e-05	0.000265	CcSEcCtD
Fluorouracil—Anorexia—Dexamethasone—psoriasis	3.42e-05	0.000265	CcSEcCtD
Fluorouracil—Urticaria—Prednisolone—psoriasis	3.41e-05	0.000264	CcSEcCtD
Fluorouracil—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.39e-05	0.000263	CcSEcCtD
Fluorouracil—Pain—Triamcinolone—psoriasis	3.38e-05	0.000262	CcSEcCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	3.37e-05	0.00132	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.37e-05	0.00132	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	3.36e-05	0.00132	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.36e-05	0.00132	CbGpPWpGaD
Fluorouracil—Hypotension—Betamethasone—psoriasis	3.35e-05	0.000259	CcSEcCtD
Fluorouracil—Hypotension—Dexamethasone—psoriasis	3.35e-05	0.000259	CcSEcCtD
Fluorouracil—Pruritus—Cyclosporine—psoriasis	3.34e-05	0.000259	CcSEcCtD
Fluorouracil—Urticaria—Hydrocortisone—psoriasis	3.33e-05	0.000258	CcSEcCtD
Fluorouracil—Body temperature increased—Hydrocortisone—psoriasis	3.32e-05	0.000257	CcSEcCtD
Fluorouracil—Convulsion—Prednisone—psoriasis	3.32e-05	0.000257	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.27e-05	0.000253	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Betamethasone—psoriasis	3.27e-05	0.000253	CcSEcCtD
Fluorouracil—Pruritus—Mycophenolate mofetil—psoriasis	3.26e-05	0.000252	CcSEcCtD
Fluorouracil—Myalgia—Prednisone—psoriasis	3.26e-05	0.000252	CcSEcCtD
Fluorouracil—Feeling abnormal—Triamcinolone—psoriasis	3.26e-05	0.000252	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—psoriasis	3.25e-05	0.000251	CcSEcCtD
Fluorouracil—Insomnia—Dexamethasone—psoriasis	3.24e-05	0.000251	CcSEcCtD
Fluorouracil—Insomnia—Betamethasone—psoriasis	3.24e-05	0.000251	CcSEcCtD
Fluorouracil—Diarrhoea—Cyclosporine—psoriasis	3.23e-05	0.00025	CcSEcCtD
Fluorouracil—Paraesthesia—Betamethasone—psoriasis	3.22e-05	0.000249	CcSEcCtD
Fluorouracil—Paraesthesia—Dexamethasone—psoriasis	3.22e-05	0.000249	CcSEcCtD
Fluorouracil—Discomfort—Prednisone—psoriasis	3.22e-05	0.000249	CcSEcCtD
Fluorouracil—UMPS—Metabolism—PPARG—psoriasis	3.21e-05	0.00126	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	3.2e-05	0.00126	CbGpPWpGaD
Fluorouracil—Erythema—Methotrexate—psoriasis	3.2e-05	0.000247	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisolone—psoriasis	3.17e-05	0.000245	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	3.16e-05	0.00124	CbGpPWpGaD
Fluorouracil—Dyspepsia—Dexamethasone—psoriasis	3.16e-05	0.000244	CcSEcCtD
Fluorouracil—Dyspepsia—Betamethasone—psoriasis	3.16e-05	0.000244	CcSEcCtD
Fluorouracil—Diarrhoea—Mycophenolate mofetil—psoriasis	3.15e-05	0.000244	CcSEcCtD
Fluorouracil—Urticaria—Triamcinolone—psoriasis	3.14e-05	0.000243	CcSEcCtD
Fluorouracil—Body temperature increased—Triamcinolone—psoriasis	3.12e-05	0.000242	CcSEcCtD
Fluorouracil—Dizziness—Cyclosporine—psoriasis	3.12e-05	0.000242	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisone—psoriasis	3.12e-05	0.000242	CcSEcCtD
Fluorouracil—Oedema—Prednisone—psoriasis	3.12e-05	0.000242	CcSEcCtD
Fluorouracil—Decreased appetite—Dexamethasone—psoriasis	3.12e-05	0.000241	CcSEcCtD
Fluorouracil—Decreased appetite—Betamethasone—psoriasis	3.12e-05	0.000241	CcSEcCtD
Fluorouracil—ALB—Selenium Micronutrient Network—CRP—psoriasis	3.12e-05	0.00122	CbGpPWpGaD
Fluorouracil—Infection—Prednisone—psoriasis	3.1e-05	0.00024	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Betamethasone—psoriasis	3.1e-05	0.00024	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Dexamethasone—psoriasis	3.1e-05	0.00024	CcSEcCtD
Fluorouracil—Hypersensitivity—Hydrocortisone—psoriasis	3.09e-05	0.000239	CcSEcCtD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.08e-05	0.00121	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP2S1—psoriasis	3.07e-05	0.00121	CbGpPWpGaD
Fluorouracil—Pain—Dexamethasone—psoriasis	3.07e-05	0.000237	CcSEcCtD
Fluorouracil—Pain—Betamethasone—psoriasis	3.07e-05	0.000237	CcSEcCtD
Fluorouracil—Nervous system disorder—Prednisone—psoriasis	3.06e-05	0.000237	CcSEcCtD
Fluorouracil—DPYD—Metabolism—CAT—psoriasis	3.06e-05	0.0012	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CAT—psoriasis	3.06e-05	0.0012	CbGpPWpGaD
Fluorouracil—Tachycardia—Prednisone—psoriasis	3.05e-05	0.000236	CcSEcCtD
Fluorouracil—Dizziness—Mycophenolate mofetil—psoriasis	3.05e-05	0.000236	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—psoriasis	3.01e-05	0.000233	CcSEcCtD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	3.01e-05	0.00118	CbGpPWpGaD
Fluorouracil—Vomiting—Cyclosporine—psoriasis	3e-05	0.000232	CcSEcCtD
Fluorouracil—UPP2—Metabolism—PPARG—psoriasis	2.99e-05	0.00117	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PPARG—psoriasis	2.99e-05	0.00117	CbGpPWpGaD
Fluorouracil—Rash—Cyclosporine—psoriasis	2.98e-05	0.00023	CcSEcCtD
Fluorouracil—Anorexia—Prednisone—psoriasis	2.98e-05	0.00023	CcSEcCtD
Fluorouracil—Dermatitis—Cyclosporine—psoriasis	2.98e-05	0.00023	CcSEcCtD
Fluorouracil—Pruritus—Hydrocortisone—psoriasis	2.97e-05	0.00023	CcSEcCtD
Fluorouracil—Headache—Cyclosporine—psoriasis	2.96e-05	0.000229	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—psoriasis	2.96e-05	0.000229	CcSEcCtD
Fluorouracil—Feeling abnormal—Betamethasone—psoriasis	2.96e-05	0.000229	CcSEcCtD
Fluorouracil—Feeling abnormal—Dexamethasone—psoriasis	2.96e-05	0.000229	CcSEcCtD
Fluorouracil—Vomiting—Mycophenolate mofetil—psoriasis	2.93e-05	0.000227	CcSEcCtD
Fluorouracil—Hypersensitivity—Triamcinolone—psoriasis	2.91e-05	0.000225	CcSEcCtD
Fluorouracil—Rash—Mycophenolate mofetil—psoriasis	2.91e-05	0.000225	CcSEcCtD
Fluorouracil—Dermatitis—Mycophenolate mofetil—psoriasis	2.9e-05	0.000225	CcSEcCtD
Fluorouracil—Headache—Mycophenolate mofetil—psoriasis	2.89e-05	0.000223	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.88e-05	0.00113	CbGpPWpGaD
Fluorouracil—Diarrhoea—Hydrocortisone—psoriasis	2.87e-05	0.000222	CcSEcCtD
Fluorouracil—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	2.86e-05	0.00112	CbGpPWpGaD
Fluorouracil—Leukopenia—Methotrexate—psoriasis	2.86e-05	0.000222	CcSEcCtD
Fluorouracil—Urticaria—Dexamethasone—psoriasis	2.85e-05	0.00022	CcSEcCtD
Fluorouracil—Urticaria—Betamethasone—psoriasis	2.85e-05	0.00022	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Prednisone—psoriasis	2.85e-05	0.00022	CcSEcCtD
Fluorouracil—Dizziness—Prednisolone—psoriasis	2.84e-05	0.00022	CcSEcCtD
Fluorouracil—Body temperature increased—Dexamethasone—psoriasis	2.84e-05	0.000219	CcSEcCtD
Fluorouracil—Body temperature increased—Betamethasone—psoriasis	2.84e-05	0.000219	CcSEcCtD
Fluorouracil—Insomnia—Prednisone—psoriasis	2.82e-05	0.000219	CcSEcCtD
Fluorouracil—ALB—SLC-mediated transmembrane transport—CP—psoriasis	2.81e-05	0.0011	CbGpPWpGaD
Fluorouracil—Nausea—Cyclosporine—psoriasis	2.81e-05	0.000217	CcSEcCtD
Fluorouracil—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	2.81e-05	0.0011	CbGpPWpGaD
Fluorouracil—Paraesthesia—Prednisone—psoriasis	2.8e-05	0.000217	CcSEcCtD
Fluorouracil—Pruritus—Triamcinolone—psoriasis	2.8e-05	0.000216	CcSEcCtD
Fluorouracil—Dizziness—Hydrocortisone—psoriasis	2.78e-05	0.000215	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—psoriasis	2.77e-05	0.000214	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.77e-05	0.00109	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—JUN—psoriasis	2.76e-05	0.00108	CbGpPWpGaD
Fluorouracil—Dyspepsia—Prednisone—psoriasis	2.75e-05	0.000213	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—IFNG—psoriasis	2.74e-05	0.00108	CbGpPWpGaD
Fluorouracil—Nausea—Mycophenolate mofetil—psoriasis	2.74e-05	0.000212	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—psoriasis	2.72e-05	0.000211	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—psoriasis	2.72e-05	0.000211	CcSEcCtD
Fluorouracil—Decreased appetite—Prednisone—psoriasis	2.72e-05	0.00021	CcSEcCtD
Fluorouracil—Rash—Prednisolone—psoriasis	2.71e-05	0.00021	CcSEcCtD
Fluorouracil—Dermatitis—Prednisolone—psoriasis	2.71e-05	0.000209	CcSEcCtD
Fluorouracil—Headache—Prednisolone—psoriasis	2.69e-05	0.000208	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—psoriasis	2.69e-05	0.000208	CcSEcCtD
Fluorouracil—Vomiting—Hydrocortisone—psoriasis	2.67e-05	0.000207	CcSEcCtD
Fluorouracil—Rash—Hydrocortisone—psoriasis	2.65e-05	0.000205	CcSEcCtD
Fluorouracil—Dermatitis—Hydrocortisone—psoriasis	2.64e-05	0.000205	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—psoriasis	2.63e-05	0.000204	CcSEcCtD
Fluorouracil—Headache—Hydrocortisone—psoriasis	2.63e-05	0.000203	CcSEcCtD
Fluorouracil—Dizziness—Triamcinolone—psoriasis	2.61e-05	0.000202	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—psoriasis	2.61e-05	0.000202	CcSEcCtD
Fluorouracil—Infection—Methotrexate—psoriasis	2.59e-05	0.000201	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisone—psoriasis	2.57e-05	0.000199	CcSEcCtD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.56e-05	0.00101	CbGpPWpGaD
Fluorouracil—Nervous system disorder—Methotrexate—psoriasis	2.56e-05	0.000198	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—psoriasis	2.56e-05	0.000198	CcSEcCtD
Fluorouracil—Nausea—Prednisolone—psoriasis	2.55e-05	0.000198	CcSEcCtD
Fluorouracil—Pruritus—Dexamethasone—psoriasis	2.54e-05	0.000196	CcSEcCtD
Fluorouracil—Pruritus—Betamethasone—psoriasis	2.54e-05	0.000196	CcSEcCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.51e-05	0.000987	CbGpPWpGaD
Fluorouracil—Vomiting—Triamcinolone—psoriasis	2.51e-05	0.000194	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle, Mitotic—PCNA—psoriasis	2.5e-05	0.000982	CbGpPWpGaD
Fluorouracil—Nausea—Hydrocortisone—psoriasis	2.49e-05	0.000193	CcSEcCtD
Fluorouracil—Rash—Triamcinolone—psoriasis	2.49e-05	0.000193	CcSEcCtD
Fluorouracil—ABCG2—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000978	CbGpPWpGaD
Fluorouracil—Dermatitis—Triamcinolone—psoriasis	2.49e-05	0.000193	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—psoriasis	2.49e-05	0.000193	CcSEcCtD
Fluorouracil—Urticaria—Prednisone—psoriasis	2.48e-05	0.000192	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Hydrocortisone—psoriasis	2.48e-05	0.00938	CbGdCrCtD
Fluorouracil—Headache—Triamcinolone—psoriasis	2.48e-05	0.000192	CcSEcCtD
Fluorouracil—Body temperature increased—Prednisone—psoriasis	2.47e-05	0.000191	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Hydrocortisone—psoriasis	2.46e-05	0.00928	CbGdCrCtD
Fluorouracil—Diarrhoea—Dexamethasone—psoriasis	2.45e-05	0.00019	CcSEcCtD
Fluorouracil—Diarrhoea—Betamethasone—psoriasis	2.45e-05	0.00019	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—psoriasis	2.44e-05	0.000189	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—psoriasis	2.38e-05	0.000184	CcSEcCtD
Fluorouracil—PPAT—Metabolism—APOE—psoriasis	2.38e-05	0.000933	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—APOE—psoriasis	2.38e-05	0.000933	CbGpPWpGaD
Fluorouracil—Dizziness—Dexamethasone—psoriasis	2.37e-05	0.000183	CcSEcCtD
Fluorouracil—Dizziness—Betamethasone—psoriasis	2.37e-05	0.000183	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—psoriasis	2.36e-05	0.000183	CcSEcCtD
Fluorouracil—Nausea—Triamcinolone—psoriasis	2.35e-05	0.000182	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—psoriasis	2.34e-05	0.000181	CcSEcCtD
Fluorouracil—MTHFR—Metabolism—CARM1—psoriasis	2.34e-05	0.000918	CbGpPWpGaD
Fluorouracil—TYMS—Clobetasol propionate—Betamethasone—psoriasis	2.33e-05	0.00882	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Dexamethasone—psoriasis	2.33e-05	0.00882	CbGdCrCtD
Fluorouracil—Dyspnoea—Methotrexate—psoriasis	2.33e-05	0.00018	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—psoriasis	2.32e-05	0.00018	CcSEcCtD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	2.32e-05	0.000909	CbGpPWpGaD
Fluorouracil—TYMS—Flunisolide—Dexamethasone—psoriasis	2.3e-05	0.00871	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Betamethasone—psoriasis	2.3e-05	0.00871	CbGdCrCtD
Fluorouracil—Hypersensitivity—Prednisone—psoriasis	2.3e-05	0.000178	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—psoriasis	2.3e-05	0.000178	CcSEcCtD
Fluorouracil—ALB—Folate Metabolism—NFKB1—psoriasis	2.28e-05	0.000896	CbGpPWpGaD
Fluorouracil—TYMS—Clobetasol propionate—Triamcinolone—psoriasis	2.28e-05	0.00862	CbGdCrCtD
Fluorouracil—Vomiting—Betamethasone—psoriasis	2.28e-05	0.000176	CcSEcCtD
Fluorouracil—Vomiting—Dexamethasone—psoriasis	2.28e-05	0.000176	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Betamethasone—psoriasis	2.28e-05	0.00862	CbGdCrCtD
Fluorouracil—TYMS—Triamcinolone—Dexamethasone—psoriasis	2.28e-05	0.00862	CbGdCrCtD
Fluorouracil—Decreased appetite—Methotrexate—psoriasis	2.27e-05	0.000176	CcSEcCtD
Fluorouracil—CYP2A6—Metabolism—NDUFA5—psoriasis	2.26e-05	0.000889	CbGpPWpGaD
Fluorouracil—Rash—Betamethasone—psoriasis	2.26e-05	0.000175	CcSEcCtD
Fluorouracil—Rash—Dexamethasone—psoriasis	2.26e-05	0.000175	CcSEcCtD
Fluorouracil—Dermatitis—Dexamethasone—psoriasis	2.26e-05	0.000175	CcSEcCtD
Fluorouracil—Dermatitis—Betamethasone—psoriasis	2.26e-05	0.000175	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—psoriasis	2.25e-05	0.000174	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Triamcinolone—psoriasis	2.25e-05	0.00851	CbGdCrCtD
Fluorouracil—Headache—Dexamethasone—psoriasis	2.25e-05	0.000174	CcSEcCtD
Fluorouracil—Headache—Betamethasone—psoriasis	2.25e-05	0.000174	CcSEcCtD
Fluorouracil—TYMS—Cell Cycle—PCNA—psoriasis	2.24e-05	0.000878	CbGpPWpGaD
Fluorouracil—Pain—Methotrexate—psoriasis	2.23e-05	0.000173	CcSEcCtD
Fluorouracil—TYMS—Fluticasone Propionate—Betamethasone—psoriasis	2.22e-05	0.00841	CbGdCrCtD
Fluorouracil—TYMS—Fluticasone Propionate—Dexamethasone—psoriasis	2.22e-05	0.00841	CbGdCrCtD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.21e-05	0.000869	CbGpPWpGaD
Fluorouracil—Pruritus—Prednisone—psoriasis	2.21e-05	0.000171	CcSEcCtD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	2.21e-05	0.000867	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—TNF—psoriasis	2.18e-05	0.000857	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CAT—psoriasis	2.18e-05	0.000856	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IFNG—psoriasis	2.18e-05	0.000856	CbGpPWpGaD
Fluorouracil—TYMS—Fluticasone Propionate—Triamcinolone—psoriasis	2.17e-05	0.00821	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisone—psoriasis	2.16e-05	0.00818	CbGdCrCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.15e-05	0.000846	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Methotrexate—psoriasis	2.15e-05	0.000166	CcSEcCtD
Fluorouracil—Diarrhoea—Prednisone—psoriasis	2.14e-05	0.000165	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisone—psoriasis	2.14e-05	0.00807	CbGdCrCtD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.13e-05	0.000837	CbGpPWpGaD
Fluorouracil—Nausea—Betamethasone—psoriasis	2.13e-05	0.000165	CcSEcCtD
Fluorouracil—Nausea—Dexamethasone—psoriasis	2.13e-05	0.000165	CcSEcCtD
Fluorouracil—ABCG2—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000832	CbGpPWpGaD
Fluorouracil—TYMS—Triamcinolone—Prednisone—psoriasis	2.11e-05	0.00799	CbGdCrCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisolone—psoriasis	2.11e-05	0.00799	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Betamethasone—psoriasis	2.1e-05	0.00794	CbGdCrCtD
Fluorouracil—TYMS—Diflorasone—Dexamethasone—psoriasis	2.1e-05	0.00794	CbGdCrCtD
Fluorouracil—TYMS—Flunisolide—Prednisolone—psoriasis	2.08e-05	0.00788	CbGdCrCtD
Fluorouracil—Urticaria—Methotrexate—psoriasis	2.07e-05	0.00016	CcSEcCtD
Fluorouracil—PPAT—Metabolism—PPARG—psoriasis	2.07e-05	0.000813	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PPARG—psoriasis	2.07e-05	0.000813	CbGpPWpGaD
Fluorouracil—Dizziness—Prednisone—psoriasis	2.07e-05	0.00016	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisolone—psoriasis	2.06e-05	0.0078	CbGdCrCtD
Fluorouracil—Body temperature increased—Methotrexate—psoriasis	2.06e-05	0.00016	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Triamcinolone—psoriasis	2.05e-05	0.00776	CbGdCrCtD
Fluorouracil—ABCC5—Metabolism—CARM1—psoriasis	2.04e-05	0.000799	CbGpPWpGaD
Fluorouracil—Vomiting—Prednisone—psoriasis	1.99e-05	0.000154	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Hydrocortisone—psoriasis	1.98e-05	0.0075	CbGdCrCtD
Fluorouracil—Rash—Prednisone—psoriasis	1.97e-05	0.000152	CcSEcCtD
Fluorouracil—Dermatitis—Prednisone—psoriasis	1.97e-05	0.000152	CcSEcCtD
Fluorouracil—Headache—Prednisone—psoriasis	1.96e-05	0.000151	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisone—psoriasis	1.95e-05	0.00737	CbGdCrCtD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.93e-05	0.00076	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP2S1—psoriasis	1.92e-05	0.000756	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Methotrexate—psoriasis	1.92e-05	0.000149	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisolone—psoriasis	1.9e-05	0.00719	CbGdCrCtD
Fluorouracil—TYMS—Danazol—Hydrocortisone—psoriasis	1.9e-05	0.00719	CbGdCrCtD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.9e-05	0.000746	CbGpPWpGaD
Fluorouracil—Nausea—Prednisone—psoriasis	1.86e-05	0.000144	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—psoriasis	1.85e-05	0.000143	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Betamethasone—psoriasis	1.84e-05	0.00696	CbGdCrCtD
Fluorouracil—TYMS—Budesonide—Dexamethasone—psoriasis	1.84e-05	0.00696	CbGdCrCtD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—psoriasis	1.82e-05	0.000716	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	1.81e-05	0.000712	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CARM1—psoriasis	1.81e-05	0.000712	CbGpPWpGaD
Fluorouracil—TYMS—Budesonide—Triamcinolone—psoriasis	1.8e-05	0.0068	CbGdCrCtD
Fluorouracil—Diarrhoea—Methotrexate—psoriasis	1.79e-05	0.000138	CcSEcCtD
Fluorouracil—ALB—Platelet degranulation—VEGFA—psoriasis	1.78e-05	0.000697	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TNF—psoriasis	1.78e-05	0.000697	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL6—psoriasis	1.76e-05	0.000692	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.74e-05	0.000684	CbGpPWpGaD
Fluorouracil—Dizziness—Methotrexate—psoriasis	1.73e-05	0.000134	CcSEcCtD
Fluorouracil—ALB—Hemostasis—ITGAL—psoriasis	1.71e-05	0.000671	CbGpPWpGaD
Fluorouracil—TYMS—Budesonide—Prednisone—psoriasis	1.71e-05	0.00646	CbGdCrCtD
Fluorouracil—TYMP—Metabolism—APOE—psoriasis	1.69e-05	0.000665	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	1.69e-05	0.000664	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—IL6—psoriasis	1.67e-05	0.000656	CbGpPWpGaD
Fluorouracil—TYMS—Budesonide—Prednisolone—psoriasis	1.67e-05	0.0063	CbGdCrCtD
Fluorouracil—Vomiting—Methotrexate—psoriasis	1.66e-05	0.000128	CcSEcCtD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.66e-05	0.000651	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.66e-05	0.000651	CbGpPWpGaD
Fluorouracil—Rash—Methotrexate—psoriasis	1.65e-05	0.000127	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—psoriasis	1.64e-05	0.000127	CcSEcCtD
Fluorouracil—TYMS—Danazol—Prednisone—psoriasis	1.64e-05	0.00619	CbGdCrCtD
Fluorouracil—Headache—Methotrexate—psoriasis	1.64e-05	0.000127	CcSEcCtD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.61e-05	0.000632	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—psoriasis	1.57e-05	0.000615	CbGpPWpGaD
Fluorouracil—Nausea—Methotrexate—psoriasis	1.55e-05	0.00012	CcSEcCtD
Fluorouracil—ABCC4—Hemostasis—NOS2—psoriasis	1.55e-05	0.000608	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NDUFA5—psoriasis	1.55e-05	0.000607	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NDUFA5—psoriasis	1.54e-05	0.000604	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CARM1—psoriasis	1.5e-05	0.000589	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PPARG—psoriasis	1.48e-05	0.000579	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.44e-05	0.000566	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CAT—psoriasis	1.44e-05	0.000565	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.43e-05	0.000563	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL6—psoriasis	1.43e-05	0.000563	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HLA-A—psoriasis	1.43e-05	0.000561	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.43e-05	0.000561	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.41e-05	0.000554	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.4e-05	0.000551	CbGpPWpGaD
Fluorouracil—TYMS—Levonorgestrel—Hydrocortisone—psoriasis	1.36e-05	0.00515	CbGdCrCtD
Fluorouracil—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.36e-05	0.000535	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—APOE—psoriasis	1.33e-05	0.000524	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2S1—psoriasis	1.31e-05	0.000516	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2S1—psoriasis	1.31e-05	0.000513	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NDUFA5—psoriasis	1.26e-05	0.000494	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CAT—psoriasis	1.25e-05	0.000492	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HLA-A—psoriasis	1.24e-05	0.000488	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NOS2—psoriasis	1.24e-05	0.000488	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.17e-05	0.000461	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—APOE—psoriasis	1.16e-05	0.000456	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.14e-05	0.000447	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—APOE—psoriasis	1.12e-05	0.000439	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CAT—psoriasis	1.11e-05	0.000438	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOS2—psoriasis	1.08e-05	0.000425	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NDUFA5—psoriasis	1.08e-05	0.000422	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2S1—psoriasis	1.07e-05	0.00042	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CARM1—psoriasis	1.03e-05	0.000406	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TYK2—psoriasis	1.02e-05	0.0004	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1e-05	0.000394	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PPARG—psoriasis	9.73e-06	0.000382	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—APOE—psoriasis	9.73e-06	0.000382	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CARM1—psoriasis	9.4e-06	0.000369	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CAT—psoriasis	9.23e-06	0.000362	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD4—psoriasis	9.21e-06	0.000362	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2S1—psoriasis	9.14e-06	0.000359	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—psoriasis	8.97e-06	0.000352	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TYK2—psoriasis	8.86e-06	0.000348	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APOE—psoriasis	8.66e-06	0.00034	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PPARG—psoriasis	8.47e-06	0.000333	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—psoriasis	8.22e-06	0.000323	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD4—psoriasis	8.02e-06	0.000315	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	7.88e-06	0.000309	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PPARG—psoriasis	7.55e-06	0.000296	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APOE—psoriasis	7.17e-06	0.000282	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—psoriasis	7.13e-06	0.00028	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS2—psoriasis	7.01e-06	0.000275	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.89e-06	0.000271	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.85e-06	0.000269	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—psoriasis	6.78e-06	0.000266	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CARM1—psoriasis	6.42e-06	0.000252	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CARM1—psoriasis	6.38e-06	0.000251	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAT—psoriasis	6.36e-06	0.00025	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—psoriasis	6.25e-06	0.000245	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—psoriasis	6.21e-06	0.000244	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6e-06	0.000236	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.97e-06	0.000234	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAT—psoriasis	5.78e-06	0.000227	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.61e-06	0.00022	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CARM1—psoriasis	5.22e-06	0.000205	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—psoriasis	4.98e-06	0.000196	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—psoriasis	4.94e-06	0.000194	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.88e-06	0.000192	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.79e-06	0.000188	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—psoriasis	4.49e-06	0.000176	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CARM1—psoriasis	4.46e-06	0.000175	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—psoriasis	4.34e-06	0.00017	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—psoriasis	4.31e-06	0.000169	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.17e-06	0.000164	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—psoriasis	4.06e-06	0.000159	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAT—psoriasis	3.95e-06	0.000155	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAT—psoriasis	3.93e-06	0.000154	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—psoriasis	3.91e-06	0.000154	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAT—psoriasis	3.21e-06	0.000126	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—psoriasis	3.07e-06	0.00012	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—psoriasis	3.07e-06	0.00012	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—psoriasis	3.05e-06	0.00012	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAT—psoriasis	2.75e-06	0.000108	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—psoriasis	2.67e-06	0.000105	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—psoriasis	2.66e-06	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—psoriasis	2.5e-06	9.81e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—psoriasis	2.18e-06	8.54e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—psoriasis	2.13e-06	8.38e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—psoriasis	1.86e-06	7.3e-05	CbGpPWpGaD
